InnovAge Holding Corp.
NASDAQ:INNVMedical - Care Facilities
-$0.01 today
- Market cap
- $1.22B
- Beta
- 0.45
- P/E (TTM)
- -55.8
- EPS (TTM)
- -$0.16
Volume 0.52M
Average 0.29M
INNV EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
InnovAge Holding Corp.NASDAQ: INNV
EBITDA · Q3 FY2026 · quarter ended Mar 2026
EBITDA remains negative
Q3 FY2026 EBITDA was -$23.96M, compared with -$4.52M a year earlier. Trailing-twelve-month EBITDA was $4.36M. Over 3 fiscal years it compounded at -28.5% a year.
Context
- EBITDA amounted to 0.4% of revenue in FY2025, up 0.2 pp from a year earlier.
- EBITDA increased in 2 of the last 3 fiscal years.
What to watch
Whether EBITDA reaches the consensus estimate from 3 analysts of $24.23M (+620.3%) for the fiscal year ending Jun 2026, a step up from the +191.5% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -$23.96M-229.0% QoQ
- Last fiscal yearJun 2025
- $3.36M+191.5% YoY
- LTMMar 2026
- $4.36M+191.5% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -430.7% | +577.3% | +1008.0 pp |
| 1 year | +191.5% | +620.3% | +428.8 pp |
| 3-year CAGR | -28.5% | +229.6% | +258.1 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- 3.36M USD
- Year-over-year change
- +191.5%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-06-30 | 3.36M | +191.5% |
| FY2024 | 2024-06-30 | 1.15M | +103.4% |
| FY2023 | 2023-06-30 | (33.85M) | -467.4% |
| FY2022 | 2022-06-30 | 9.21M | +256.5% |
| FY2021 | 2021-06-30 | (5.89M) | — |
EBITDA vs competitors
How INNV compares with its peers on the latest reported figures
- INNV's LTM Mar 2026 EBITDA of $4.36M is the lowest of the 8 companies compared; the peer median is $207.86M.
- Its year-over-year change of +191.5% is the highest of 8, against a peer median of +18.2%.
- EBITDA amounts to 0.5% of revenue for INNV, versus a peer median of 11.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $621.28M | +18.2% | +16.4% | 11.3% | |
| LTM Sep 2026 | $411.59M | -8.8% | +3.9% | 14.0% | |
| LTM Oct 2026 | $347.65M | +31.1% | — | 13.0% | |
| LTM Sep 2026 | $207.86M | +10.1% | +46.3% | 13.1% | |
| LTM Jun 2026 | $167.37M | +23.6% | +22.7% | 11.3% | |
| LTM Mar 2026 | $60.01M | +22.5% | +51.2% | 5.9% | |
| LTM Mar 2026 | $5M | -88.2% | +10.6% | 1.2% | |
| LTM Mar 2026 | $4.36M | +191.5% | -28.5% | 0.5% | |
| Peer median (excluding INNV) | $207.86M | +18.2% | +19.5% | 11.3% | |
Competitors are the stored peer set for INNV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Jun 2021 | FY2022 Jun 2022 | FY2023 Jun 2023 | FY2024 Jun 2024 | FY2025 Jun 2025 |
|---|---|---|---|---|---|
| Revenue | 637.8M | 698.64M | 688.09M | 763.86M | 853.7M |
| Cost of Revenue | 476.01M | 563.27M | 586.8M | 631.79M | 268.91M |
| Gross Profit | 161.79M | 135.37M | 101.29M | 132.06M | 584.79M |
| Gross Margin | 25.4% | 19.4% | 14.7% | 17.3% | 68.5% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 154.57M | 125.85M | 135.26M | 136.29M | 150.28M |
| Operating Expenses | 86.96M | 139.78M | 150.68M | 155.24M | 614.55M |
| Depreciation & Amortization | 12.29M | 13.92M | 15.42M | 18.95M | 19.51M |
| EBITDA | (5.89M) | 9.21M | (33.85M) | 1.15M | 3.36M |
| EBITDA Margin | -0.9% | 1.3% | -4.9% | 0.2% | 0.4% |
| Operating Income | 74.82M | (4.41M) | (49.4M) | (23.18M) | (29.76M) |
| Operating Margin | 11.7% | -0.6% | -7.2% | -3.0% | -3.5% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 16.79M | 2.53M | 1.52M | 4.02M | 4.61M |
| Other Income / Expenses | (109.79M) | (2.83M) | (1.4M) | 1.36M | (4.27M) |
| Income Before Tax | (34.97M) | (7.24M) | (50.79M) | (21.82M) | (34.03M) |
| Pre-Tax Margin | -5.5% | -1.0% | -7.4% | -2.9% | -4.0% |
| Income Tax Expense | 9.77M | 723K | (7.24M) | 1.4M | 1.32M |
| Net Income | (43.99M) | (6.52M) | (40.67M) | (21.34M) | (30.31M) |
| Net Margin | -6.9% | -0.9% | -5.9% | -2.8% | -3.6% |
| EPS (Basic) | (0.33) | (0.05) | (0.30) | (0.16) | (0.22) |
| EPS (Diluted) | (0.33) | (0.05) | (0.30) | (0.16) | (0.22) |
| Weighted Avg Shares | 135.52M | 135.52M | 135.59M | 135.9M | 135.39M |
| Weighted Avg Shares (Diluted) | 135.52M | 135.52M | 135.59M | 135.9M | 135.39M |
InnovAge Holding Corp.
NASDAQ:INNV
Intrinsic Alpha fair value
Locked
Current Price
$8.91
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.